- £62.26m
- £41.46m
- £34.50m
- 95
- 69
- 14
- 65
2018 March 31st | R2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 13.2 | 21.9 | 29 | 28.1 | 34.5 |
Cost of Revenue | |||||
Gross Profit | 13 | 21.5 | 28.6 | 27.6 | 33.9 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 7.02 | 19.7 | 18.7 | 20.3 | 24.1 |
Operating Profit | 6.22 | 2.25 | 10.3 | 7.8 | 10.4 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 6.17 | 2.14 | 10.2 | 7.4 | 10 |
Provision for Income Taxes | |||||
Net Income After Taxes | 6.17 | 2.14 | 8.09 | 5.9 | 7.4 |
Net Income Before Extraordinary Items | |||||
Net Income | 6.17 | 2.14 | 8.09 | 5.9 | 7.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 6.17 | 2.14 | 8.09 | 5.9 | 7.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.055 | 0.097 | 0.087 | 0.057 | 0.068 |
Dividends per Share |